Effect of hypoxia and endothelial loss on vascular smooth muscle cell responsiveness to VEGF-A: Role of flt-1/VEGF-receptor-1

Cardiovascular Research

Volumn 55, Issue 1, 2002, Pages 201-212

  Parenti, Astrid ^a   Brogelli, Laura ^a   Filippi, Sandra ^a   Donnini, Sandra ^b   Ledda, Fabrizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Endothelial factors, hypoxia anoxia; Remodeling; Smooth muscle; Vasoconstriction dilation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; FIBRIN; GROWTH FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PLACENTAL GROWTH FACTOR 1; PROTEIN FARNESYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; GEL; HYPOXIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR RING; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANOXIA; AORTA; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX PROTEINS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASOCONSTRICTION;

EID: 0036275712     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00326-7     Document Type: Article

References (33)

1. The pathophysiology of the collateral circulation (arteriogenesis)
2. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion
3. Fluid shear stress increases the production of granulocyte-macrophage colony-stimulating factor by endothelial cells via mRNA stabilization
4. Early expression of angiogenesis factors in acute myocardial ischemia and infarction
5. The biology of vascular endothelial growth factor
6. Vascular endothelial growth factor (VEGF) and its receptors
7. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
8. Gene therapy for collateral vessel development
9. Stent endothelization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration and response to cytokine expedition
10. Vascular endothelial growth factor: How it transmits its signal
11. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediates via the VEGF receptor VEGFR-1
12. Vascular endothelial growth factor increases the mitogenic response to fibroblast growth factor-2 in vascular smooth muscle cells in vivo via expression of fms-like tyrosine kinase-1
13. Angiotensin II potentiates the mitogenic effect of noradrenaline in vascular smooth muscle cells: Role of FGF-2
14. Inhibition of vascular smooth muscle cell growth by angiotensin type 2 receptor stimulation in an in vitro organ culture model
15. Vasorelaxant effect induced by the angiogenic drug Linomide in aortic and saphenous vein preparations of the rabbit
16. Augmented membrane type 1 matrix metalloproteinase (MT1-MMP): MMP2 messenger RNA ratio in gastric carcinomas with poor prognosis
17. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy
18. Regulation of vascular endothelial growth factor in cardiac myocytes
19. A novel in vitro assay for human angiogenesis
20. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor
21. Ras farnesylation as a target for novel antitumor agents: Potent and selective farnesyl diphosphate analog inhibitors of farnesyltransferase
22. A synthetic inhibitor of the mitogen-activated protein kinase cascade
23. Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening. Biochemical and morphologic studies
24. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt-1
25. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
26. Placental growth factor-1 is chemotactic, mitogenic, and angiogenic
27. Arteriogenesis, the good and bad of it
28. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart
29. Role of endothelial carbon monoxide in attenuated vasoreactivity following chronic hypoxia
30. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. VEGFR-1, but not Flk-1/KDR, is up-regulated by hypoxia
31. Endogenous regulation of angiogenesis in the rat aorta model. Role of vascular endothelial growth factor
32. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries
33. Coronary vasoconstriction during myocardial ischemia induced by rises in metabolic demand in patients with coronary artery disease